Trial Profile
Alpha-2 Adrenergic Antagonist Treatment of Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Fipamezole (Primary)
- Indications Dyskinesias; Parkinson's disease
- Focus Therapeutic Use
- 09 Sep 2014 New trial record